Synergen Inc. has recruited Nigel G. Goodman to be director ofEuropean marketing and business affairs for the company'sEuropean operations, to be located in Amsterdam, theNetherlands. Goodman joins Synergen after a 17-year career atHoffmann-La Roche, where he was Amgen-Roche marketingdirector. Synergen also appointed Paul Koivuniemi, Ph.D.,corporate patent counsel. He was biotechnology patentsdirector and senior patent counsel at The Upjohn Co. Synergen(NASDAQ: SYGN) of Boulder, Colo., is developing protein-basedpharmaceuticals.

E-Z-EM Inc., a Westbury, N.Y., manufacturer of medicalproducts, has appointed Robert M. Bloomfield president andchief executive officer of its recently formed subsidiary, EntericProducts Inc. EPI develops immunodiagnostic tests,pharmaceuticals and devices for the detection, diagnosis andtreatment of gastrointestinal diseases. Bloomfield was E-Z-EM'sdirector of corporate development and vice president andgeneral manager of its Immulogical Products Group.

Epitope Inc. of Beaverton, Ore., has promoted Elaine Dubesa tovice president for regulatory affairs. Epitope (AMEX:EPT) isdeveloping diagnostic tests for AIDS and other indications,anti-microbial drugs and new plant varieties, through itsagricultural unit, Agritope Inc.

Diacrin Inc., a Charlestown, Mass., developer of cellulartransplantation for treating diseases, has appointed Janice W.Maran, Ph.D., vice president of market development. Maranwas director of business development at Parexel InternationalCorp.

Collagen Corp. of Palo Alto, Calif., has promoted Frank DeLustroto senior vice president of scientific affairs. Collagen(NASDAQ:CGEN) develops biomedical devices to augment andrepair aged or damaged tissues.

Arcturus Pharmaceutical Corp. has appointed R. Dana Ono, Ph.D.,president and chief executive officer. Ono was vice president ofbusiness development at Enzytech Inc. Arcturus of Cambridge,Mass., is developing a non-steroidal compound to treatpsoriasis, eczema and other dermatoses.

(c) 1997 American Health Consultants. All rights reserved.